Hypothesis: macrophages as effector cells for human tumor destruction mediated by monoclonal antibody

Detection of HLA class II-dependent T helper antigen using antigen phage display.

Clinical and experimental immunology·2004

[1st successful immunization of pancreas and colorectal carcinoma patients with CO17-1A-vaccine].

Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress·2003

Addition of interleukin-12 to GA733 tumor protein vaccine leads to development of tumor protective immunity despite surgical stress.

Surgical endoscopy·2003

Anti-idiotypic antibody (ab2) vaccines: coupling of Ab2 BR3E4 to KLH increases humoral and/or cellular immune responses in animals and colorectal cancer patients.

Journal of cancer research and clinical oncology·2002

Recombinant vaccinia viruses expressing immunoglobulin variable regions efficiently and selectively protect mice against tumoral B-cell growth.

Cancer gene therapy·2001

Anti-idiotypic antibody and recombinant antigen vaccines in colorectal cancer patients.

Critical reviews in oncology/hematology·2001

A monoclonal antibody specific for Pseudomonas aeruginosa amidase.

Hybridoma·2001

Characterization of monoclonal antibodies against carcinoembryonic antigen (CEA) and expression in E. coli.

Hybridoma·2001

Generation and characterization of monoclonal antibodies against the E6 and E7 oncoproteins of HPV.

Hybridoma·2001

Monoclonal antibodies against human telomerase reverse transcriptase (hTERT): preparation, characterization, and application.

Hybridoma·2001

Evaluation of clinical significance of isoferritin by development of new monoclonal antibodies specific for acidic isoferritin.

Hybridoma·2001

Production, characterization, and epitope mapping of monoclonal antibodies against human polydeoxyribonucleotide kinase.

Hybridoma·2001

ITPRIPL1: A tumor immune-associated biomarker with prognostic and therapeutic implications in gastrointestinal cancer.

Scientific reports·2026

Differential effects of BCG-Russia and BCG-TICE on trained immunity: Potential implications for bladder cancer immunotherapy.

PloS one·2026

Spatial statistics infer structured immune signatures in primary prostate cancer.

Cancer immunology research·2026

Integrated molecular and immune profiling identifies FOXA1 as a complementary co-target to MUC1 for bispecific immunotherapy in breast cancer.

Functional & integrative genomics·2026

Incidental Thyroid Uptake on 18F-FES PET/CT Revealing Papillary Thyroid Carcinoma.

Clinical nuclear medicine·2026

IL-23 promotes PD-L1 expression and tumor immune evasion via METTL16 pathway.

American journal of cancer research·2026

Related Experiment Videos

Hypothesis: macrophages as effector cells for human tumor destruction mediated by monoclonal antibody

Related Concept Videos

Detection of HLA class II-dependent T helper antigen using antigen phage display.

[1st successful immunization of pancreas and colorectal carcinoma patients with CO17-1A-vaccine].

Addition of interleukin-12 to GA733 tumor protein vaccine leads to development of tumor protective immunity despite surgical stress.

Anti-idiotypic antibody (ab2) vaccines: coupling of Ab2 BR3E4 to KLH increases humoral and/or cellular immune responses in animals and colorectal cancer patients.

Recombinant vaccinia viruses expressing immunoglobulin variable regions efficiently and selectively protect mice against tumoral B-cell growth.

Anti-idiotypic antibody and recombinant antigen vaccines in colorectal cancer patients.

A monoclonal antibody specific for Pseudomonas aeruginosa amidase.

Characterization of monoclonal antibodies against carcinoembryonic antigen (CEA) and expression in E. coli.

Generation and characterization of monoclonal antibodies against the E6 and E7 oncoproteins of HPV.

Monoclonal antibodies against human telomerase reverse transcriptase (hTERT): preparation, characterization, and application.

Evaluation of clinical significance of isoferritin by development of new monoclonal antibodies specific for acidic isoferritin.

Production, characterization, and epitope mapping of monoclonal antibodies against human polydeoxyribonucleotide kinase.

ITPRIPL1: A tumor immune-associated biomarker with prognostic and therapeutic implications in gastrointestinal cancer.

Differential effects of BCG-Russia and BCG-TICE on trained immunity: Potential implications for bladder cancer immunotherapy.

Spatial statistics infer structured immune signatures in primary prostate cancer.

Integrated molecular and immune profiling identifies FOXA1 as a complementary co-target to MUC1 for bispecific immunotherapy in breast cancer.

Incidental Thyroid Uptake on 18F-FES PET/CT Revealing Papillary Thyroid Carcinoma.

IL-23 promotes PD-L1 expression and tumor immune evasion via METTL16 pathway.

Related Experiment Videos

Hypothesis: macrophages as effector cells for human tumor destruction mediated by monoclonal antibody

Related Concept Videos

Related Articles